These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37871869)

  • 1. A comprehensive evaluation of arginine and its derivatives as protein formulation stabilizers.
    Hada S; Burlakoti U; Kim KH; Han JS; Kim MJ; Kim NA; Jeong SH
    Int J Pharm; 2023 Nov; 647():123545. PubMed ID: 37871869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermal aggregation of human immunoglobulin G in arginine solutions: Contrasting effects of stabilizers and destabilizers.
    Yoshizawa S; Arakawa T; Shiraki K
    Int J Biol Macromol; 2017 Nov; 104(Pt A):650-655. PubMed ID: 28647523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-Acetylated-L-arginine (NALA) is an enhanced protein aggregation suppressor under interfacial stresses and elevated temperature for protein liquid formulations.
    Kim NA; Hada S; Jeong SH
    Int J Biol Macromol; 2021 Jan; 166():654-664. PubMed ID: 33137385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orthogonal Techniques to Study the Effect of pH, Sucrose, and Arginine Salts on Monoclonal Antibody Physical Stability and Aggregation During Long-Term Storage.
    Svilenov HL; Kulakova A; Zalar M; Golovanov AP; Harris P; Winter G
    J Pharm Sci; 2020 Jan; 109(1):584-594. PubMed ID: 31689429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced protein aggregation suppressor activity of N-acetyl-l-arginine for agitation-induced aggregation with silicone oil and its impact on innate immune responses.
    Kim NA; Noh GY; Hada S; Na KJ; Yoon HJ; Park KW; Park YM; Jeong SH
    Int J Biol Macromol; 2022 Sep; 216():42-51. PubMed ID: 35779650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of arginine glutamate on the stability of monoclonal antibodies in solution.
    Kheddo P; Tracka M; Armer J; Dearman RJ; Uddin S; van der Walle CF; Golovanov AP
    Int J Pharm; 2014 Oct; 473(1-2):126-33. PubMed ID: 24992318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arginine and its Derivatives Suppress the Opalescence of an Antibody Solution.
    Oki S; Nishinami S; Nakauchi Y; Ogura T; Shiraki K
    J Pharm Sci; 2022 Apr; 111(4):1126-1132. PubMed ID: 34843741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of solvent environment on the conformation and stability of human polyclonal IgG in solution.
    Szenczi A; Kardos J; Medgyesi GA; Závodszky P
    Biologicals; 2006 Mar; 34(1):5-14. PubMed ID: 16168667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of thermally induced aggregation of IgG antibodies by noncovalent interaction with poly(acrylate) derivatives.
    Martin N; Ma D; Herbet A; Boquet D; Winnik FM; Tribet C
    Biomacromolecules; 2014 Aug; 15(8):2952-62. PubMed ID: 25019321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agitation-induced aggregation and subvisible particulate formation in model proteins.
    Jayaraman M; Buck PM; Ignatius AA; King KR; Wang W
    Eur J Pharm Biopharm; 2014 Jul; 87(2):299-309. PubMed ID: 24462794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginine suppresses opalescence and liquid-liquid phase separation in IgG solutions.
    Oki S; Nishinami S; Shiraki K
    Int J Biol Macromol; 2018 Oct; 118(Pt B):1708-1712. PubMed ID: 29981328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A change in the aggregation pathway of bovine serum albumin in the presence of arginine and its derivatives.
    Borzova VA; Markossian KA; Kleymenov SY; Kurganov BI
    Sci Rep; 2017 Jun; 7(1):3984. PubMed ID: 28638090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of Colloidal and Conformational Stabilities to Aggregate Formation in a Monoclonal Antibody.
    Oyama H; Koga H; Tadokoro T; Maenaka K; Shiota A; Yokoyama M; Noda M; Torisu T; Uchiyama S
    J Pharm Sci; 2020 Jan; 109(1):308-315. PubMed ID: 31669120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic Effect of Cavitation and Agitation on Protein Aggregation.
    Torisu T; Maruno T; Hamaji Y; Ohkubo T; Uchiyama S
    J Pharm Sci; 2017 Feb; 106(2):521-529. PubMed ID: 27887723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced Subvisible Particle Formation in Lyophilized Intravenous Immunoglobulin Formulations Containing Polysorbate 20.
    Zhou C; Qi W; Lewis EN; Randolph TW; Carpenter JF
    J Pharm Sci; 2016 Aug; 105(8):2302-9. PubMed ID: 27290624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allantoin and hydantoin as new protein aggregation suppressors.
    Nishinami S; Yoshizawa S; Arakawa T; Shiraki K
    Int J Biol Macromol; 2018 Jul; 114():497-503. PubMed ID: 29505874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine dipeptides affect insulin aggregation in a pH- and ionic strength-dependent manner.
    Nuhu MM; Curtis R
    Biotechnol J; 2015 Mar; 10(3):404-16. PubMed ID: 25611817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of arginine on photostability and thermal stability of IgG1 monoclonal antibodies.
    Maity H; O'Dell C; Srivastava A; Goldstein J
    Curr Pharm Biotechnol; 2009 Dec; 10(8):761-6. PubMed ID: 19939215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Charge state of arginine as an additive on heat-induced protein aggregation.
    Miyatake T; Yoshizawa S; Arakawa T; Shiraki K
    Int J Biol Macromol; 2016 Jun; 87():563-9. PubMed ID: 26987431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular computations of preferential interactions of proline, arginine.HCl, and NaCl with IgG1 antibodies and their impact on aggregation and viscosity.
    Cloutier TK; Sudrik C; Mody N; Hasige SA; Trout BL
    MAbs; 2020; 12(1):1816312. PubMed ID: 32938318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.